145 related articles for article (PubMed ID: 26612291)
1. Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.
Jiang X; Deng CY; Sun ZY; Chen WL; Wang HB; Zhou YZ; Jin L
Chin Med J (Engl); 2015 Dec; 128(23):3167-72. PubMed ID: 26612291
[TBL] [Abstract][Full Text] [Related]
2. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
[TBL] [Abstract][Full Text] [Related]
3. Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study.
Hu L; Xie R; Wang M; Sun Y
Reprod Biol Endocrinol; 2021 Jan; 19(1):8. PubMed ID: 33441149
[TBL] [Abstract][Full Text] [Related]
4. The Association between Ovarian Hyperstimulation Syndrome and Pregnancy Complications following Fertility Treatments.
Vainer-Rotbart S; Sheiner E; Harlev A; Bar G; Levy A
Am J Perinatol; 2023 Jul; 40(10):1088-1095. PubMed ID: 34327685
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients.
Ren Y; Li R; Yang S; Yang R; Song D
Arch Gynecol Obstet; 2022 Jun; 305(6):1587-1594. PubMed ID: 35059793
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
[TBL] [Abstract][Full Text] [Related]
7. [Perinatal outcome among women undergoing in vitro fertilization procedures complicated by ovarian hyperstimulation syndrome].
Serdyńska-Szuster M; Jedrzejczak P; Ozegowska K; Korman M; Pawelczyk L
Ginekol Pol; 2012 Feb; 83(2):104-10. PubMed ID: 22568354
[TBL] [Abstract][Full Text] [Related]
8. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
9. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
[TBL] [Abstract][Full Text] [Related]
10. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.
Zhang JJ; Merhi Z; Yang M; Bodri D; Chavez-Badiola A; Repping S; van Wely M
Am J Obstet Gynecol; 2016 Jan; 214(1):96.e1-8. PubMed ID: 26259908
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.
Luke B; Brown MB; Morbeck DE; Hudson SB; Coddington CC; Stern JE
Fertil Steril; 2010 Sep; 94(4):1399-1404. PubMed ID: 19591989
[TBL] [Abstract][Full Text] [Related]
12. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.
Walls ML; Hunter T; Ryan JP; Keelan JA; Nathan E; Hart RJ
Hum Reprod; 2015 Jan; 30(1):88-96. PubMed ID: 25355587
[TBL] [Abstract][Full Text] [Related]
13. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.
Steward RG; Lan L; Shah AA; Yeh JS; Price TM; Goldfarb JM; Muasher SJ
Fertil Steril; 2014 Apr; 101(4):967-73. PubMed ID: 24462057
[TBL] [Abstract][Full Text] [Related]
14. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
Das M; Son WY; Buckett W; Tulandi T; Holzer H
Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of severe late-onset ovarian hyperstimulation syndrome and its impact on the live birth outcome of IVF-ET].
Ma XW; Yin JW; Yang R; Yang S; Li J; Wang Y; Li R
Zhonghua Fu Chan Ke Za Zhi; 2022 Sep; 57(9):678-685. PubMed ID: 36177579
[No Abstract] [Full Text] [Related]
16. Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study.
Abramov Y; Elchalal U; Schenker JG
Fertil Steril; 1998 Dec; 70(6):1070-6. PubMed ID: 9848297
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
18. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
[TBL] [Abstract][Full Text] [Related]
20. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
